6-(Hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,5-triol

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-(Hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,5-triol
• 化学式: C₁₂H₂₂O₁₁
• 分子量: 342.3
• InChiKey: QIGJYVCQYDKYDW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -4.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  190
• 氢给体数：
  8
• 氢受体数：
  11

文献信息

• MEDIUM WITH A PLANT NON-METABOLIZABLE SUGAR FOR IMPROVING SEED GERMINATION
  申请人：WEYERHAEUSER NR COMPANY

  公开号：US20160081336A1

  公开（公告）日：2016-03-24

  What is described is a nutritive media for a manufactured seed comprising a plant non-metabolizable sugar and a manufactured seed comprising plant non-metabolizable sugar in its nutritive medium
• METHODS OF IMPROVING GERMINATION OF PLANT EMBRYOS
  申请人：WEYERHAEUSER NR COMPANY

  公开号：US20170035011A1

  公开（公告）日：2017-02-09

  A method of improving germination of plant embryos is provided. The method entails treating a culture of plant tissue with a liquid multiplication medium comprising a plant non-metabolizable sugar. Also provided is a multiplication medium for liquid cultures of plant cells comprising isomaltulose.
• Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
  申请人：Wang Tianxin

  公开号：US20180161410A1

  公开（公告）日：2018-06-14

  The current invention discloses methods to modify protein and peptide and antigen to treat disease such as pathogen infection, autoimmune diseases and cancer. The method involves increasing the molecular weight of the protein by connecting multiple peptide units with site specific conjugation to extend the in vivo half life. The current invention also discloses methods to construct activatable enzyme, which becomes active when they reach the treatment target, therefore provide higher specificity for treatment. The current invention also relates to methods to treat disease with hemopurification.
• Methods to Treat Diseases with Protein, Peptide and Antigen Modification
  申请人：Wang Tianxin

  公开号：US20190160160A1

  公开（公告）日：2019-05-30

  This disclosure provides methods to modify protein and peptide and antigen to treat disease such as pathogen infection, autoimmune diseases and cancer. The method involves increasing the molecular weight of the protein by connecting multiple peptide units with site specific conjugation to extend the in vivo half life. This disclosure also provides methods to construct activatable enzyme, which becomes active when they reach the treatment target, therefore provide higher specificity for treatment.
• METHOD OF CONVERTING LACTOSE-CONTAINING DAIRY BY-PRODUCTS INTO MONOSACCHARIDES
  申请人：Wisconsin Alumni Research Foundation

  公开号：US20190289867A1

  公开（公告）日：2019-09-26

  A method of making a solution containing glucose and galactose. The method includes the steps of reducing the concentration of non-protein nitrogen-containing (NPN) compounds in a dairy by-product stream comprising lactose to yield a reduced-NPN dairy by-product stream; and contacting the reduced-NPN dairy by-product stream of step (a) with an acid catalyst at a temperature of from about 120° C. to about 200° C., and for a time of from about 1 minute to about 180 minutes, wherein at least a portion of the lactose contained in the reduced-NPN dairy by-product stream is hydrolyzed to monosaccharides comprising glucose and galactose. The dairy by-product stream may be ultrafiltered prior to reducing its NPN concentration.